Paliperidone Palmitate*
-
API Product :
Paliperidone Palmitate*
-
CEP :
-
-
WCC :
?
-
Therapeutic Use :
Psycholeptics
-
Originator :
JANSSEN PHARM
-
CAS No. :
144598-75-4
-
Trade Name. :
INVEGA SUSTENNA
-
Molecular Weight :
426.484 g/mol
-
Molecular Formula :
C23H27FN4O3
Application
This medication is used to treat certain mental/mood disorders (such as schizophrenia, schizoaffective disorder). Paliperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural chemicals (neurotransmitters) in the brain.
General Description
Paliperidone, sold under the trade name Invega among others, is a dopamine antagonist and 5-HT2A antagonist of the atypical antipsychotic class of medications. It is marketed by Janssen Pharmaceutica. Invega is an extended release formulation of paliperidone that uses the OROS extended release system to allow for once-daily dosing. Paliperidone is mainly used to treat schizophrenia and schizoaffective disorder. It is also used to treat mania and at lower doses as maintenance for bipolar disorder.